Clinical Trials Directory

Trials / Unknown

UnknownNCT02475928

Zinc Supplementation in Cirrhotic Patients

Zinc Supplementation as Treatment of Dysgeusias in Cirrhotic Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Fundación Clínica Médica Sur · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of zinc supplementation in the treatment for dysgeusia, progression disease and quality of life in patients with liver cirrhosis.

Detailed description

Taste disorders are symptomatologies in patients with cirrhosis, these have a direct effect in modification of food consumption, increasing weight loss, anorexia and malnutrition, which impacts in decompensation rates and mortality. It has been proposed that zinc deficiency is one of the causes for development of taste disorders. The aim of this study is to describe the presence of taste disorders in patients with cirrhosis and evaluate the effect of zinc supplementation in treatment of taste disorders, and in progression of chronic liver disease.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTzinc gluconateZinc supplementation plus nutritional education
DIETARY_SUPPLEMENTPlacebo
BEHAVIORALNutritional education

Timeline

Start date
2015-04-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2015-06-19
Last updated
2019-02-15

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT02475928. Inclusion in this directory is not an endorsement.